UNSPSC 51101684: Spirazine or spirotriazine

This classification denotes an antiparasitic agent with the molecular formula C15H20ClN5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WV516JUV0B, chemically known as 1,3,5-triazaspiro(5.5)undeca-1,3-diene, 2,4-diamino-5-(p-chlorophenyl)-9-methyl- but generally known as spirazine, which bears US NIH Compound Identifier 210321. European Medicines Agency schedules Spirazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10622MIG. The term SPIRAZINE is an International Non-Proprietary Name.

SPIRAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Spirazine or spirotriazine bears US NLM identifiers UMLS ID C2827337 and NCI Concept Code C84180. SMILES: CLC1CCC(N2C3(N=C(N=C2N)N)CCC(CC3)C)CC1.

UNSPSC 51101684 Spirazine or spirotriazine is a Commodity code that shows little relevant recent activity aligned with its nominal chemical scope. The recent opportunities tagged to this code involve naloxone procurement, pharmaceutical benefit program direct-to-manufacturer contracting, medical and first aid supplies for fire rescue, and generic multi-source pharmaceuticals through cooperative purchasing — none of which concern spirazine or spirotriazine compounds. The mismatch between the code's chemical specificity and the actual procurements suggests either a data-tagging error in the source opportunities or that state and local governments are not currently soliciting spirazine or spirotriazine products through formal RFP, RFQ, IFB, or ITB channels under this code.

The recent opportunities that have been mislabeled under this code reflect broader state and local procurement patterns in health-related products and pharmaceuticals, spanning Florida county health initiatives, Texas state pharmacy benefit programs, municipal fire departments, and multistate cooperative purchasing alliances. Geographic activity includes Florida (Seminole County), Texas (Health and Human Services Commission), and Minnesota (MMCAP with Oregon participation). However, these opportunities do not represent genuine market activity for spirazine or spirotriazine compounds, and business development professionals should not use this summary as a basis for pursuing opportunities under the stated UNSPSC code. Verification of the correct commodity code alignment with actual procurement intent is necessary before targeting these issuing bodies.